During a live event, Benjamin Garmezy, MD, discussed treatment options in renal cell carcinoma including IO/TKI combinations ...

Bekah Kooy, 38, was convinced she had food poisoning when she felt nauseated and experienced stomach pain following lunch one ...

BMS says it is combining AI and machine learning with its researchers’ expertise in drug targets and mechanisms of action, to ...

Skin cancer advanced clinical practitioners ensure continuity of care for patients with malignant melanoma and other advanced ...

Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of potential new medicine, all based on our ...

ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (the "Company", "Zefiro", or "ZEFI") today announced that it has engaged TÜV SÜD America ("TÜV SÜD"), a technical inspection association that tests, inspects, ...

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.

The trial was evaluating ciforadenant or ciforadenant as a potential first line therapy for metastatic renal cell cancer in combination with ipilimumab and nivolumab ... of the work that we ...

The FDA has completed its review of the investigational new drug application (IND) for PSV359, and issued a "study may proceed” letter in 1Q 2025. Site activation activities are underway, with the ...

SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a ...

Hispanic homeownership reached a record high, with 9.8 million Hispanic households now owning their homes. In the most recent year, Hispanic households saw a net gain of 238,000 new homeowners, ...